Global Cord Blood (NYSE:CO) Coverage Initiated at StockNews.com

Equities research analysts at StockNews.com initiated coverage on shares of Global Cord Blood (NYSE:CO) in a research report issued on Saturday. The firm set a “strong-buy” rating on the medical research company’s stock.

Global Cord Blood Price Performance

Shares of CO stock opened at $1.26 on Friday. Global Cord Blood has a 12-month low of $2.03 and a 12-month high of $5.50. The firm has a market capitalization of $153.15 million, a price-to-earnings ratio of 1.97 and a beta of 0.16. The business has a 50 day simple moving average of $1.50 and a 200 day simple moving average of $1.40.

About Global Cord Blood

Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants.